## Abstract Although imatinib mesylate (IM) has revolutionized the treatment of chronic myeloid leukemia (CML), some patients develop resistance with progression of leukemia. Alternative or additional targeting of signaling pathways deregulated in bcr‐abl‐driven CML cells may provide a feasible opt
In vitro effect of multidrug resistance modifiers on idarubicinol efflux in blasts of acute myeloid leukemia
✍ Scribed by Jan K. Schröder; Sabine Kasimir-Bauer; Siegfried Seeber; Max E. Scheulen
- Publisher
- Springer-Verlag
- Year
- 2000
- Tongue
- English
- Weight
- 363 KB
- Volume
- 126
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Bone marrow stromal cells constitute a heterogeneous population, and in the present study we investigated intercellular crosstalk __via__ release of soluble mediators between native human AML blasts and fibroblasts/osteoblasts. Coculture of nonleukemic stromal cells and AML blasts separ
The emergence of acquired drug resistance is a major hurdle in the successful treatment of leukemia. Researches indicated that the main mechanisms of most cancers included so-called "pump" and "nonpump" resistance. We studied the mechanisms involved in the drug resistance of HL-60/ADR and found that